Thomas Nee
Private Equity Investor bei Larchmont Ventures
Profil
Mr. Nee is an Operating Partner at Hildred, where he advises on commercial strategy and research across portfolio companies and investment opportunities.
Mr. Nee previously served in a similar operating role at Hildred Capital Partners leveraging his depth of experience to enhance strategic positioning, operational efficiency, and overall growth trajectory.
Mr. Nee is a member of the steering and screening committee of the Mid-Atlantic Bioangels, an angel investor group focused exclusively on new and emerging life science companies.
Mr. Nee has over 25 years experience in biopharmaceuticals and healthcare product marketing.
Mr. Nee previously served as Senior Vice President, Business Analytics & Operations at Allergan overseeing a diverse range of services including commercial deal evaluation, omni-channel marketing, market research.
Mr. Nee served in similar capacities at Forest Laboratories in addition to leadership roles in product management.
Prior to joining Forest, Mr. Nee served in Health & Personal Care brand management at Procter & Gamble.
Mr. Nee provides volunteer leadership with the national governing body of competitive cycling as chairperson of their Technical Commission and Cyclocross Sports Committee.
Mr. Nee has a M.B.A.
from Stanford Graduate School of Business and is an Aresty Scholar at The Wharton School.
Aktive Positionen von Thomas Nee
| Unternehmen | Position | Beginn |
|---|---|---|
| Larchmont Ventures | Private Equity Investor | 01.01.2016 |
Hildred Capital Management LLC
 Hildred Capital Management LLC Investment ManagersFinance Hildred Capital Management LLC (Hildred Capital) is a private equity firm founded in 2014 by David Solomon and Andrew Goldman. The firm is headquartered in New York. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Thomas Nee
| Unternehmen | Position | Ende |
|---|---|---|
| ALLERGAN PLC | Private Equity Investor | 31.12.2016 |
| FOREST LABORATORIES, INC. | Private Equity Investor | 31.12.2014 |
Ausbildung von Thomas Nee
| Stanford Graduate School of Business | Masters Business Admin |
| Santa Clara University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
| Larchmont Ventures | |
Hildred Capital Management LLC
Hildred Capital Management LLC Investment ManagersFinance Hildred Capital Management LLC (Hildred Capital) is a private equity firm founded in 2014 by David Solomon and Andrew Goldman. The firm is headquartered in New York. | Finance |
